MS drug NeuroVax partnership discussions terminated
Posted: Thu May 31, 2012 1:32 am
Immune Response BioPharma, Inc. terminates blockbuster MS drug NeuroVax partnership discusions with GlaxoSmithKline.
"Immune Response BioPharma, Inc. has the first MS Vaccine a first in class and best in class multiple sclerosis drug which restores deficient FOXP3+ T-Regs. GSK has no approved MS drug and probably will never have one they are busy wasting their shareholders money on HGSI and a Lupus drug with poor sales, we don't need them or to give away our blockbuster drug for MS to them which we believe will become treatment of choice" ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1313